Myrexis Competitors and Similar CompaniesClear all
Myrexis's competitors and similar companies include Takeda, Genocea Biosciences and Oncopeptides.
 Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Genocea Biosciences Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. | |||
Founding Date | Founding Date 1999 | Founding Date 1781 | Founding Date 2006 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations New York, US HQ | Locations Cambridge, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US | |
Employees | Employees N/A | Employees 47,4554% decrease | Employees 593% decrease | Employees 80 |
Valuation ($) | Valuation ($) 4.1 m | Valuation ($) 43.7 b | Valuation ($) 5.7 k | Valuation ($) 42.4 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $1.6m (FY, 2021) | Revenue (est.) kr71.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods N/A | Cost of goods kr2.5m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit N/A | Gross profit kr72m (FY, 2025) |
Net income | Net income N/A | Net income ¥108.1b (FY, 2025) | Net income ($33.2m) (FY, 2021) | Net income (kr249.6m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised $ 209.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyGenocea Biosciences
HQ
Cambridge, US
Employees
59↓ 3% decrease
Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.
View company
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company